Cite
Karina K, Christoffel LM, Novariani R, et al. The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on "Profibrotic Cytokine" IL-1. Scientifica (Cairo). 2021;2021:9427978doi: 10.1155/2021/9427978.
Karina, K., Christoffel, L. M., Novariani, R., Rosadi, I., Rosliana, I., Rosidah, S., Sobariah, S., Fatkhurohman, N., Puspitaningrum, N., Hertati, Y., Afini, I., Ernanda, D., Widyastuti, T., Sulaeha, A. D., Zakiyah, A., Aini, N., Krisandi, G., & Andrew, H. (2021). The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on "Profibrotic Cytokine" IL-1. Scientifica, 20219427978. https://doi.org/10.1155/2021/9427978
Karina, Karina, et al. "The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on "Profibrotic Cytokine" IL-1." Scientifica vol. 2021 (2021): 9427978. doi: https://doi.org/10.1155/2021/9427978
Karina K, Christoffel LM, Novariani R, Rosadi I, Rosliana I, Rosidah S, Sobariah S, Fatkhurohman N, Puspitaningrum N, Hertati Y, Afini I, Ernanda D, Widyastuti T, Sulaeha AD, Zakiyah A, Aini N, Krisandi G, Andrew H. The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on "Profibrotic Cytokine" IL-1. Scientifica (Cairo). 2021 Jul 08;2021:9427978. doi: 10.1155/2021/9427978. eCollection 2021. PMID: 34306796; PMCID: PMC8266471.
Copy
Download .nbib